Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|3|205-215

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.3, 2011-03, pp. : 205-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 7, 2011-03 ,pp. : 943-963

Bentham Science Publishers

Access to resources Recommend Favorite

Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

By Zámečníkova Adriana  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 77-92

Informa Healthcare

Access to resources Recommend Favorite

QSAR study on N- (Aryl)-4-(Azolylethyl) Thiazole-5-Carboxamides: Novel Potent Inhibitors of VEGF Receptors I and II

By  

Medicinal Chemistry, Vol. 5, Iss. 5, 2009-09 ,pp. : 455-461

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily: Role as Anticancer Agents

By Noonberg S.B.   Benz C.C.  

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 753-767

Adis International

Access to resources Recommend Favorite

Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes

By Prada Patricia O  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite